Kathmandu. China has approved its first oral GLP-1 group weight-loss drug. The drug named 'Orforglipron' produced by American company Eli Lilly has been allowed to be sold under the brand 'Muyuda'.China's National Medical Products Administration has approved the drug for the treatment of adults with obesity or overweight along with at least one related health problem. This drug, which needs to be taken once a day, was also approved in America last April.With this, Eli Lilly has become the first company to get an oral GLP-1 drug approved in China. However, injectable drugs of this type have already been made...